Cyrus Khan

Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Michael Dickinson, Carmelo Carlo‐Stella, Franck Morschhauser et al. · New England Journal of Medicine · 2022 · 605 citations · Full text

Azacitidine in the management of patients with myelodysplastic syndromes

Cyrus Khan, Neeta Pathe, Salman Fazal et al. · Therapeutic Advances in Hematology · 2012 · 65 citations · Full text

Hematological Malignancy, Oncology, Medicine +10

Glofitamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma: Extended Follow-Up from a Pivotal Phase II Study and Subgroup Analyses in Patients with Prior Chimeric Antigen Receptor T-Cell Therapy and by Baseline Total Metabolic Tumor Volume

Martin Hutchings, Carmelo Carlo‐Stella, Franck Morschhauser et al. · Blood · 2023 · 31 citations

Glofitamab in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and ≥ 2 prior therapies: Pivotal phase II expansion results.

Michael Dickinson, Carmelo Carlo‐Stella, Franck Morschhauser et al. · Journal of Clinical Oncology · 2022 · 26 citations

Immunology, Prior Therapies, Pathology +21

Safety and Efficacy of Atezolizumab in Combination with Rituximab Plus CHOP in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Updated Analysis of a Phase I/II Study

Anas Younes, John M. Burke, Bruce D. Cheson et al. · Blood · 2019 · 24 citations